Process for the preparation of delta**4-6 6-difluoro - 320 - diketo - 17alp ha21-dihydr-oxypregnenes

ABSTRACT

TITLE COMPOUNDS ARE PREPARED FROM $5-3-ALKANOYL17A,20; 20,21-BISMETHYLENEDIOXYPREGNENES BY A PROCESS INVOLVING THE ADDITION OF NOF; HYDROLYSIS OF THE RESULTING 5A-FLUORO-6-NITRIMINOSTEROID TO THE 5A-FLUORO-6-KETOSTEROID; HYDROLYSIS OF THE 3-ALKANOYL AND BISMETHYLENEDIOXY GROUPS WITH 48% HYDROFLUORIC ACID; ACETYLATION OF THE 3-, 17A-, AND 21-HYDROXYLS, FLUORINATION WITH SULFUR TETRAFLUORIDE TO THE CORRESPONDING 5A,6,6-TRIFLUOROSTEROID; HYDROLYSIS OF ALL ACETYL GROUPS; RE-FORMATION OF THE 17A,20; 20,21-BISMETHYLENEDIOXY GROUP; OXIDATION OF THE 3-HYDROXYL TO THE 3-KETONE; DEHYDROFLOURINATION IN THE C4-C5 POSITIONS; AND REMOVAL OF THE BISMETHYLENEDIOXY GROUP. AN ALTERNATIVE ROUTE ALSO IS PROPOSED. TITLE STEROIDS HAVING AN OXYGENATED FUNCTION IN THE 11B-POSITION ARE USEFURL ANTIINFLAMMATORY AND GLUCOCORTICAL AGENTS.

United States Patent Office I 3,641,005 Patented Feb. 8, 1972 ABSTRACT OF THE DISCLOSURE Title compounds are prepared from A -3-alkanoyl- 1711,20; 20,21-bismethylenedioxypregnenes by a process involving the addition of NOF; hydrolysis of the resulting 5a-fluoro-G-nitriminosteroid to the 5a-fluoro-6-ketosteroid; hydrolysis of the 3-alkanoy1 and bismethylenedioxy groups with 48% hydrofluoric acid; acetylation of the 3-, 17oc-, and 21-hydroxy1s, fluorination with sulfur tetrafluoride to the corresponding 5a,6,6-trifluorosteroid; hydrolysis of all acetyl groups; re-formation of the l7u,20; 20,21-bismethylenedioxy group; oxidation of the 3-hydroxy1 to the 3-ketone; dehydrofluorination in the C -C positions; and removal of the bismethylenedioxy group. An alternative route also is proposed. Title steroids having an oxygenated function in the lip-position are useful antiinflarnmatory and glucocortical agents.

BACKGROUND OF THE INVENTION Field of the invention This invention relates to a process for the preparation of certain A -6,6diflu0ro 3,20 diketo-17,21-dihydroxypregnenes, which are useful as antiinflammatory and glucocorticoid agents. These compounds are suitable for the treatment of allergic diseases, collagen diseases, skin diseases, and the like.

Prior art U.S. Pat. 3,219,673 (to Boswell) describes a general process for preparing 6,6-difiuoro-3-keto-A -steroids in which the substituents at C-17 can be among others fl-hydroxyl, aor ,B-acetoxyl, B-acetyl, and a-methyl. This patent does not disclose 6,6-difluoro-3-keto-A -steroids having either the C-17 COCH OH substituent or derivatives thereof. It is well known that the 2-hydroxy group is quite reactive and obviously would not survive certain reaction steps of the Boswell process, such as the conversion of the 6-keto group to the 6,6-difluoro group by means of SP Yet, many known biologically active steroids are derived from A -17,21-dihydroxy-20-ketopregnene, while a new class of very active antiinflammatory agents have the A -6,6-difluoro-17,21-dihydroxy-20 ketopregnene structure.

There is a need, therefore, for a reliable and inexpensive process for the production of such A -17,21-dihydroxy-ZO-ketopregnene derivatives.

SUMMARY OF THE INVENTION According to this invention, it has now been discovered that certain A -6,6-difluoro-17a,2l-dihydroxy-ZO-ketopregnenes can be prepared by a simple series of reactions in which the 1704- and 21-hydroxyls are protected -by conversion to bismethylenedioxy derivatives. The divalent bismethylenedioxy group (hereinafter, designated BMD) is shown below, together with the steroid D-ring, to which it is attached.

2 END The starting material is represented by the following Formula 1:

0 II n co in which R is two hydrogens or oxygen; and R is a C -C alkyl.

The process of this invention can be illustrated by the following Scheme 1, in which R is methyl, and the resulting acetyl group is designated Ac:

BMD R1 r\\ Nor M20352? M0 no When R is oxygen, and the ll-keto group is desired, the BMD group is hydrolyzed directly with 48% hydrofiouric acid. If the llfi-hydroxysteroid, rather than the ll-ketosteroid is desired, the following steps are added:

n 0 M n, 'F a 0 F When R is two hydrogens, the BMD group of Compound 11 is hydrolyzed with 48% hydrofluoric acid, and the resulting steroid is microbiologically hydroxylated in the llfl-position.

The above process is susceptible to variations in certain portions thereof without substantially departing from the spirit of the invention. Thus, starting with Compound 3, above, it is possible to fluorinate the C-6 position with SP then hydrolyze the 3-acetyl group, and thus obtain Compound 9 in fewer steps.

Many novel intermediates obtained in the abovedescribed process have useful biological properties and thus are valuable themselves.

DETAILED DESCRIPTION OF THE INVENTION Although the 3-hydroxy group of the starting material is usually blocked by acetylation, any other conventional, hydrolyzable ester can be formed. Suitable ester groups in the C-3 position include, for example, propionate, butyrate, isobutyrate, valerate, and isovalerate, etc., i.e. such ester groups in which R shown in Formula 1, is ethyl, propyl, isopropyl, butyl, isobutyl, sec-butyl and tertbutyl.

The BMD group can be readily introduced into a 17,2l-dihydroxy--ketopregnane derivative by reaction of the steroid with either formaldehyde or a formaldehyde source, such as paraformaldehyde or trioxane, in the presence of a strong acid. Hydrochloric acid is most practical for these reactions. The general process for making BMD derivatives of steroid compounds is known to the art and has been disclosed in both scientific and patent literature; see, for example, R. E. Beyler, F. Hoffman, and L. H. Sarett, J. Am. Chem. Soc., 82, 180 (1960).

The first step of the instant process, the reaction of Compound 1 with NOF, is carried out in an inert solvent, for instance, a halogenated hydrocarbon, such as methylene chloride, chloroform, carbon tetrachloride, fluorodichloromethane, and ethylene chloride, or mixtures of these with glyme.

The amount of nitrosyl fluoride employed must, of course, be at least stoichiometric, i.e., two moles per mole of the starting A -pregnene. However, it is advantageous to use an excess of nitrosyl fluoride. An initial molar ratio of nitrosyl fluoride to the A -pregnene of about 3 to 1 has been found to be particularly practical, high yields of the 5-fluoro-6-nitriminopregnane being obtained in short times.

The reaction is carried out at moderate temperatures, preferably no higher than about C. and especially within the range of about 10 to 30 C. Within this range, the reaction rates are satisfactory and can be easily controlled. Atmospheric pressure is suflicient, although higher pressures sometimes are required to maintain a sufficient concentration of the reactants at the reaction temperatures. Moisture is undesirable in this step because of the danger of NOF hydrolysis.

The nitrosyl fluoride adduct obtained in the first step, the 5-fluoro-6-nitrimino-BMD-pregnane, can be isolated in any conventional manner, such as for example evaporation of the solvent and recrystallization of the residue. In practice, this isolation and purification step is not required, and the crude solution can be directly subjected to the next step, i.e. conversion of the nitrimino group to the keto group.

The solution is first contacted with a weak base, such as aqueous alkali bicarbonate, to remove excess NOF and acidic reaction side products. The solution is then chromatographed on neutral alumina containing 5-15 by Weight of water (activity grade III). The 5-fluoro-6- keto-BMD-pregnane, 3, formed in this step is eluted with a suitable solvent or a solvent combination, such as aliphatic or aromatic hydrocarbons. Instead of the chromatographic technique; any other suitable technique for contacting the fluoronitrimino-pregnane solution. Alternatively, the nitrimino group can be hydrolyzed by refluxing a solution of the steroid in aqueous dioxane.

While Compound 3 can be directly fluorinated in the C-6 position, as stated above, such a direct fluorination with SP is not practical because the BMD group is to a large extent degraded by the strongly acidic SF /HF medium, and the yield of the resulting 5a,6,6-trifluoro- BMD-pregnane is low. Free hydroxyl groups, reformed by hydrolysis of the BMD group, do not survive the reaction conditions.

The preferred technique is to protect the 17- and 21- hydroxyls by acetylation. The BMD group is first hydrolyzed with 48% hydrofluoric acid at about room temperature. The 3-acetoxy group is also hydrolyzed in this step. The 3- and ZI-hydroxyls are then acetylated with acetyl chloride in pyridine at or below room temperature. The 17-hydroxyl is more resistant to acetylation but it is conveniently acetylated with acetic anhydride in the presence of p-toluenesulfonic acid. This reaction also is carried out at room temperature.

The resulting triacetoxysteroid is then contacted with sulfur tetrafluoride, which converts the 6-keto group to the 6,6-difluoro group. Hydrofluoric acid or another Lewis acid is necessary in this step as the reaction catalyst. The reaction is carried out in an inert solvent such as e.g., methylene chloride, chloroform, carbon tetrachloride, fiuoro-dichloromethane, ethylene chloride, and the like.

Sulfur tetrafluoride can be replaced by selenium tetrafluoride or by an organosulfur fluoride, such as phenylsulfur trifluoride, but sulfur tetrafluoride is the cheapest and the most readily available reagent. Since both sulfur tetrafluoride and hydrogen fluoride are gases at the reaction temperatures, it is practical to carry out this step in a closed reactor, such as a shaking autoclave. The reaction is best carried out at moderate temperatures, beusually is not practical to lower the temperature below low about 100 C., and preferably at -1O to 30 C. It

about -10 C. because the reaction rates are too low for an efiicient operation.

The relative proportions of sulfur tetrafluoride and of hydrogen fluoride can be varied within a rather broad range; the molar porportion of hydrogen fluoride in admixture with sulfur tetrafluoride can be as low as zero or as high as about 90%, the 15-20% range being perferred. Although other fluoro Lewis acids, such as BF or SbF can be used, hydrogen fluoride, either added directly or generated in situ is preferred. HF can be generated in situ by adding to the reacting mixture an active hydrogen-containing compound, such as water or alcohol. Reaction of such compound with SP liberates hydrogen fluoride. The 5,6,6-trifluoropregnane can be recovered by conventional methods, such as evaporation of solvent and recrystallization of the residue or column chromatography.

The acetyl groups are then hydrolyzed with mild alkali in an aqueous solvent. Sodium and potassium carbonates and hydroxides are particularly suitable for this reaction. Potassium carbonate is preferred because of its good solubility and because it does not cause undesirable side reactions. A water-miscible solvent such as a lower alcohol, ether or ketone can be used. A mixture of methanol and tetrahydrofuran has been found to be particularly convenient because it dissolves well both the steroid and the alkali.

Prior to the oxidation of the 3-hydroxy to the 3-ketone, the 17- and 2l-hydroxyls must again be protected. This is accomplished by re-forming the BMD group, as described above, by means of aqueous formaldehyde in the presence of hydrochloric acid. The reaction is run in a heterogeneous system, the steroid being dissolved in chloroform, and good agitation is essential. The reaction takes several hours at room temperature.

The steroid 9, obtained in the above step, is then oxidized to the 3-keto-5u,6,6-trifluoropregnane BMD derivative, 10. This is done by a conventional reaction, well known in the art. The steroid can be dissolved, for example, in a water-miscible solvent such as a lower ketone or ether and treated with aqueous chromic acid. The reaction is run at about C., and the solution is then allowed to cool to room temperature. The oxidation proceeds fast, a few minutes being suflicient for a quantitative conversion,

The dehydrofluorination at C-4-C-5 positions can be done in any conventional manner, such as, for instance, by dissolving the steroid in ethyl alcohol and adding an alcoholic solution of sodium ethoxide. In practice, it is more convenient to dissolve the steroid in hexane and chromatograph the solution on anhydrous neutral alumina. This technique is described in Boswells US. Pat. 3,219,673. The BMD group can then be hydrolyzed at room temperature by treatment with 48% hydrofluoric acid.

If there is no substituent in the C-ll position (R is two hydrogens), the resulting steroid can be microbiologically hydroxylated with a microorganism from the Curvularia family. Suitable microorganisms include Curvularia lunata and Curvularia pallescens.

If there is a keto group in the C-11 position, it can be reduced to the llfi-hydroxyl prior to the removal of the BMD group. The 3-keto group must be protected from the reducing agent. This can be done by forming a cyclic ketal with ethylene glycol in the presence of an acid catalyst. These reactions are known in steroid chemistry. Both the ethylene 'ketal and the BMD group are then hydrolyzed with 48% hydrofluoric acid in the manner described above.

If desired, a double bond at C-l-C-Z can also be introduced. This step is accomplished by a microbiological method employing the microorganism Arthrobacter simplex.

The final products, whether or not 1,2-unsaturated, and having an ll-keto or an llfi-hydroxyl substituent are useful antiinflammatory and glucocortical agents. They in which R is R or one int-hydrogen and one fi-hydroxyl; X is the bismethylenedioxy group or the group, in which each of R and R is individually hydrogen or acetyl group; Y is the nitrinu'no group, oxygen, or two fluorine atoms; Z is oxygen or one a-hydrogen and one fl-hydroxyl or one tat-hydrogen and one o s-llon group, where R is a C -C1, alkyl.

This invention is now illustrated by the following examples of certain preferred embodiments thereof, in which all temperatures arein degrees centigrade, and all proportions and percentages are by weight unless otherwise specified.

EXAMPLE 1.-6,6-difluorocortisol en oa c=o Ho ox In formulas below, the abbreviation BMD stands for "bismethylenedioxy." (A) Se-fluoro-17a,20:20,21-bismethylenedioxy-3fi-hydroxypregnane-6,20-dione 3-a-cetate (1) 1711,20 ;20,21-BISMETHYLENEDIOXY-3B-HYDROXY- PREGN-5-EN-1l-ONE- 3-ACETATE .I..NOF

2.Al O;(H 0) AcO l? A stirred solution of Compound 16 [J. H. Fried, A. N. Nutile, and G. E. Arth, J. Org. Chem. 26, 976 (1961)] (84.5 g.) in 1000 ml. of THF and 500 ml. of methanol was treated portion-wise with sodium borohydride (13 g.) and the mixture was allowed to stir for 16 hours at room temperature. The reaction mixture was taken to dryness under reduced pressure; the resultant residue, suspended in water, collected by filtration, washed well with water and air dried, yielded 78.3 g. of 35-01. This was acetylated by dissolving in acetic anhydride (400 ml.) and pyridine (150 ml.) and stirring overnight at room temperature.

Cooling the reaction mixture precipitated a small amount of 3,8,11,6-diacetate, yield 2 g. The filtrate was diluted with water liters) and the precipitated solid was collected. This in 400 ml. of acetone was oxidized with 8 N chromic acid reagent to convert any 115-01 to ll-one. The reaction mixture was filtered and the filtrate partitioned between methylene chloride and water, the organic phase dried over anhydrous calcium sulfate, filtered, evaporated to dryness under reduced pressure to give 17 (70 g.); M.P. 157-162 C.

Analysis.-Calcd. for C H O (percent): C, 67.24; H, 7.68. Found (percent): C, 67.21; H, 7.76.

Nitrosyl Fluoride Addition to A -Steroids-General Procedure: In a dry, SOD-ml. polyethylene bottle equipped with a magnetic stirring bar and polyethylene gas inlet and exit tubes was placed a solution of A -steroid (1-60 g.) in methylene chloride or carbon tetrachloride (100- 250 ml.). The exit tube was protected by a drying tube containing calcium chloride, and the system was swept with a stream of nitrogen to remove moisture and air. The reactor was cooled in an ice bath, while a slow stream of nitrosyl fluoride (0.33 to 0.5 times the weight of A -steroid charged) was passed into the stirred solution over 3 to 7 hours. During this time, after an initial induction period of 4-2 hours depending on the rate of flow, the reaction solution became deep blue. As the reaction proceeded the color gradually turned green and finally straw. The reaction mixture was washed with water and saturated salt solution, dried over magnesium sulfate, and evaporated under reduced pressure. The viscous residue was either crystallized from the appropriate solvent system to furnish the fiuoronitrimine or chromatographed on neutral Activity 'Grade III alumina (20-30 g. per g.) of starting A -steroid. The eluted solids were crystallized from the appropriate solvent system to furnish the fiuoroketone.

Compound 17 (22.5 g.) treated with NOF (ca. g.) in the presence of suspended sodium fluoride (10 g.) to bind any hydrogen fluoride gave fiuoroketone 18 (10.8 g., 50% yield after recrystallization from acetonehexane): M.P. 213-215; [(1113 -60; A 298 ma (6 70).

Analysis.Calcd. for C H FO (percent): C, 62.48; H, 6.93; F, 3.96. Found (percent): C, 62.72; H, 7.03; F, 4.09.

(B) 5 a-fluoro-3 5, 17 (1,2 1-trihydroxy-pregnan-6,1 1,20- trione (4) AcO ACO

Three grams of fiuoroketone 19 in 50 ml. pyridine was cooled to 0, and 1.5 g. of acetyl chloride was added. The solution was stirred overnight at 25 then diluted with water. The precipitate was collected, washed with water and dried to give 1.479 g. of 5a-flUOlO-3fi,17oc,2ltrihydroxy-pregnan-6,11,20-trione 3,21-diacetate 20.

NMR H 37 c.p.s. (H-18); 63 c.p.s. (H-19); 122 c.p.s. and c.p.s. (acetates at C-3 and C-21); 320 c.p.s. (H21).

The crude material from above (1.47 g.) was suspended in a mixture of 30 ml. acetic anhydride and 0.58 g. ptoluenesulfonic acid and stirred at 25 for 24 hrs. It was then cooled in ice and diluted with water. The solid precipitate was collected, washed with water and dried to give 1.464 g. of 5a-fluoro-3p,17a,21-trihydroxy-pregnan- 6,11,20-tri0ne 3,17,21-t-riacetate 21.

NMR F doublet at +9250, 9275 c.ps. (F-5a) NMR H 39 c.p.s. (H-l8); 61 c.p.s. (H-19); 121 and 128 c.p.s. (acetates at C-3, C-17, C-21); 283 c.p.s. (H-21).

9 (D) 5a,6,6-trifluoro-3/8,17u,21-trihydroxypregnan-11,20-dione (22) 21 SF4/HF AcO .A mixture of 1.3 g. of steroid fiuoroketone 21, 20 ml. of methylene chloride, 0.14 ml. of water and 15 g. of sulfur tetrafluoride was allowed to react at 20i2 for 20 hrs. The reaction was poured into water and the organic layer washed well with saturated aqueous sodium bicarbonate, water, and brine. It was dried (MgSO and evaporated. The residue was crystallized from acetone to give (L806 g. of 5a,6,6 trifiuoro-3 3,17a,2l-trihydroxypregnan-l1,20-dione 3,17,21-triacetate 22.

NMR F +6000 c.p.s. (F6ot,fl); doublet at +9370, 9415 (F-Su).

NMR H +43 c.p.s. (H-18), multiplet at 77 c.p.s. (H-19); 123 and 130 c.p.s. (acetates at C-3, C-17 and C-21); 287 c.p.s. (H-21).

(D) 5u,6,6-trifiuoro-3fi,17oz,2l-trihydroxy-pregnan- 11,20-dione 23) 48B O Y Steroid triacetate (22), 1.088 g. in a solution of 200 m1. deaerated methanol and 100 ml. deaerated tetrahydrofuran, under nitrogen and at 25 was treated with 420 mg. of potassium carbonate in 12 ml. of Water. Stirring was continued at 25 for 6 hrs.; then, the reaction was diluted with water and extracted with ethyl acetate to give 3 3,17a,21-trihydroxy-5a,6,6-triflu0ropregnan-11,20-dione 23.

(E) 5a,6,6-trifluoro-3p,17a,2l-trihydroxy-pregnan- 11,20-dione BMD (24) rim 5 (a) CHCl (b) 80% HOAc Steroid 23, 1.5 g. in 180 ml. of chloroform was stirred at 25 with 45 ml. of 40% formaldehyde solution and 45 ml. of concentrated hydrochloric acid for 60 hrs. The organic layer was separated and the aqueous layer extracted several times with chloroform. The combined chloroform solutions were washed with aqueous sodium bicarbonate, water, dried (MgSO and evaporated to give a partially crystalline residue. This crude residue was hydrolyzed with boiling aqueous acetic acid 'ml.) of 0.5 hr. Precipitation with water gave 50 6,6- trifiuoro-3B,17a,2l-trihydroxy-pregnan 11,20 dione bismethylenedioxy derivative 24, M.P. 200202 C.

Infrared (CHCl soln.): 2.82,u (sharp, free OH), 3.08; (broad, bonded OH) and 5.82p. (11 C=0).

NMR H (CDCl soln.): 0.79 (Cl8), triplet 1.25

(1:3 c.p.s., C-19), 1.70 (OH), 3.95 (21H), 5.0, 5.06

and 5.18 p.p.m. (two -OCH O-groups).

A solution of 0.61 g. (1.32 mmoles) of trifluoride 24 in 50 ml. of acetone cooled in an ice bath was treated dropwise with 0.65 ml. of 8 N chromic acid reagent. When the addition had been completed, the ice 'bath was removed and the orange-red reaction mixture was stirred for an additional 15 mins. Methanol (1 ml.) was then added, the reaction mixture stirred for 10 mins. and filtered into 1400 ml. of ice water. The white solid which separated was collected by filtration to give 0.55 g. (93%) of 5a,6,6 trifluoro-l7a,20,20,2l-bismethylenedioxypregnane-3,l1-dione 25, M.P. 203204 C. (dec.).

Infrared (Nujol): Sh. 5.82,u. (3 C=0) and 5.86 (11 0:0).

NMR H (CD61 soln.): 0.85 (C-18), 1.27 (C-19), 3.97 (21-H), 5.02 and'5.20 p.p.m. (two O--CHO- groups).

(G) 6,6-difluoro-17a,20; 20,21-bismethylenedioxypregn-4-ene-3,1l-dione (26) The trifluorodione, 25 (1.668 g., 3.63 mmoles) was dissolved in benzene and chromatographed on a column of 60 g. of neutral Activity Grade III alumina. The column was developed with hexane, and the product 26 was then eluted with benzene, 1.54 g. (97%).

Infrared (CHCl soln.): Sh. 5.85 (C-ll C=0) 5.92; (3 C=0) and Sh. at 6.02/L (C=C).

NMR H (CDCl soln.): 0.85 (C-18), doublet at 1.48 (1:2 c.p.s., C-19), 3.97 (21-1-1), multiplet at 4.98, 5.04, 5.05 and 5.18 (two OCH O groups), and a doublet at 6.25 p.p.m. (J=4 c.p.s., 4-H).

NMR F (CD01 soln., 56.4 mc. vs. internal F-ll): a poorly resolved AB pattern at +4700, +4965, +5635 and +5889 c.p.s. (triplet J=4.54 c.p.s.) the two lower signals being further split.

1 1 (H) 6,6-difluoro-3-ethylenedioxy-17a,20;20,2l-bismethylenedioxy-4-pregnen-1 l-one (27) 6 Ethylene glycol The difiuorodione 26 (1.668 g., 3.82 mmoles) was dissolved in 100 ml. of benzene and treated with 2.9 ml. of ethylene glycol and 270 mg. of oxalic acid dihydrate. The reaction mixture was heated at reflux temperature under a Dean-Stark tube overnight and washed in turn with a standard aqueous solution of sodium bicarbonate, with water, with a saturated aqueous sodium chloride solution and dried (CaSO The filtered solution was taken to dryness in vacuo to give 1.54 g. (83%) of the ketal 27.

NMR H (CDCl so1n.): 0.85 (C-18), 1.25 (ethylenedioxy group), a doublet at 1.48 (1:25 c.p.s., C-19), 3.97 (21-H), a multiplet at 5.00, 5.05, 5.06 and 5.20 (two -OCH -O- groups) and a doublet at 6.25 p.p.m. (J=4 c.p.s., 4-H).

(I) 6,6-difluoro-3-ethylenedioxy-17u,20;20,2l-bismethylenedioxy-4-pregnen-1 1 B-ol (28) BMD NaBH

A solution of 210 mg. (0.436 mmole) of the difluoroketone 27 in 25 ml. of tetrahydrofuran and 25 ml. of methanol was treated with 250 mg. of sodium borohydride. The reaction mixture was stirred at ambient temperature for 26 hrs. and concentrated in vacuo. Water was added to the concentrate to precipitate the llfl-alcohol 28 189 mg. (89%) M.P. 104-108 C.

Infrared (CDCl soln.): 2.76 and 2.88;) free and bonded OH respectively).

NMR H (CDCl soln.): 1.11 (C-l8), 1.25 (ethylenedioxy group), a doublet at 1.40 (1:45 c.p.s., C-19), 3.98 (C-21), 5.0 and 5.20 (two -O-CH -O groups) and a doublet at 5.90 p.p.m. (J =4 c.p.s., 4-H) NMR P (CDCl soln.), 56.4 (rnc., vs. internal F-ll): an AB pattern at +4660, +4900, +5494 and 5834 c.p.s. the two lower signals being further split into triplets (1:40 c.p.s.).

(J) 6,6-difluorocortisol (29) CH OH The difluoroalcohol 29 (250 mg., 0.516 mmole) in a 1 oz. polyethylene bottle was treated with 2.5 ml. of 48% hydrofluoric acid and stirred for mins. while cooling in an ice bath. By the end of this period some oily solid remained on the walls of the bottle, the remainder having dissolved. The reaction mixture was then poured into an aqueous potassium carbonate solution. The polyethylene bottle was washed with tetrahydrofuran and the washings also poured into the potassium carbonate solution. The product was then extracted with ethyl acetate and the resulting organic phase washed with a saturated aqueous sodium chloride solution and dried (Ca'SO The filtered solution was taken to dryness in vacuo to give 210 mg. of a crystalline solid mixture consisting of equal amounts of the steroids 29 and 30 along with a small amount of unchanged 28. The NMR F spectrum (deuterio-acetonevs. internal F-l 1) of this mixture accordingly shows three overlapping AB patterns the two lower signals being forther split and ranging from +4544-4943 c.p.s. The higher field half of the pattern exhibits weak signals at +5605 and +5856 c.p.s. for unchanged 28 and approximately equally intense signals at +5518, +5551, +5763 and +5805 c.p.s. for 29 and 30.

The mixture was readily resolved by this layer chromatography using a Brinkman silica gel F-254 plate and ethyl acetate development. The following Rf values were observed: 0.25 (30), 0.52 and 0.56 (29 and 28).

Although the protecting groups can also be removed with acetic acid, the reaction is not as clean, and the hydrochloric acid method appears to be superior.

PURIFICATION, ISOLATION AND CHARACTERIZATION OF 6,6-DIFLUOROCORTISOL (29) The mixture of 28, 29 and 30 (210 mg.) was chromatographed on Florisil (25 g.) prepared in hexane. Cuts 52-55 (91 mg.) solidified on standing; NMR H (d-acetone), 0.92 (IS-H), 1.53 (19-H, doublet, J=3 Hz.) 2.91 (OH), 6.03 p.p.m. (4-H, doublet, J=4 -Hz.); )t 226 (e 6000), 273 (e 270), and 282 (e 235).

Analysis.-(mass spectrum) Calcd. for C H F O (percent) 398.1905. Found (percent): 398.1908.

Cut 52 crystallized from acetane-hexane, M.P. 225- 230".

EXAMPLE 2.-ALTERNATIVE ROUTE TO COMPOUND 24 (A) 5a,6,6-trifluoro-17u,20; 20,21-bismethylenedioxy- 3 3-hydroxypregnan-1 l-one 3-acetate (3 1) CH2? AcO A Hastelloy bomb containing fluoroketone 18 (1.0 g.), water (0.5 ml.), THF (3 ml.), SP (about 40 g.), and methylene chloride (25 ml.) was shaken for 10 13 y t hours at 20i2. The bomb was vented ,and the reaction mixture was worked up in the usual manner (washed with water, 5% sodium bicarbonate solution, dried over MgSO and evaporated to dryness under reduced pressure) to give a solid residue (1 g.). The NMR H spectrum (CDCI showed a good conversion (at least 50%) of 18 to the trilluoride 31: l8H' (0.78 p.p.m.) 19H (1.25 p.p.ni.). The 19-Hs of fluoroketone 18 appear at 1.0-1.05 p.p.m. Chromatography on Florisil followed by ,crystalliration of the appropriate fractions as determined by ,NMR H spectra from acetone-hexane and then hexane gave the trifiuoroketone 31 (33 mg.): M.P. 104-108"; :[cd -44.

Analysis.-Calcd. for C25H33F3O7 (percent): C, 59.8; H, 6.62. Bound (percent): 0, 60.18; H, 6.91. The mass spectrum showed a weak parent ion:(502 m/e); the most abundant m'/ e ion was 474.

Continued elution of the column with increasing amounts of acetone in hexane (24%; acetone by volume) gave. mixtures of unchanged 18 and3l and finally relatively pure"'18. Compounds 18 and 31 are difiicult to sep arate by either column or preparative thin layer chromatography.

This solution was stirred at ambient temperature for 20.

hrs. while passing nitrogen through this solution during the entire period. The reaction mixture was poured into 1000 ml. of ice water and the white solid 24 which separated was collected by filtration, 0.621 g. (89%), M.P. 200 202? C.

Infrared (CHCl soln.): 2.82 4 (sharp, free OH), 3.08 1. (broad, bonded OH) and 5.82 (11 C=O).

NMR H (CDCl soln.): 0.79 (C -18), tri let 1.25 (I= 3 c.p.s C-19), 1.70 (OH), 3.95 (21-H), 5.0, 5.06 and 5.18 p.p.m. (two--CH -O"-groups).

Difluoror ocortisol, compound 29, "is effective as an antiinfiammatory agent and has a good glucocorticoid activity..-

Antiinflammatory activity was measured on 2l-day-old male rats by inuncting an 0.05 ml. solution of the steroid in -20% pyridine, 5% water, 74% diethyl ether and 1% croton oil to each the inside and outside of an ear with the total dose of steroid varied froin 0.3 to 2.7 g. Ears wre removed 6 hrs. after administration and uniform pieces punched out and weighed. :The weight decreases were compared to a control in which no steroid was used to show this activity.

Topically applied antiinfiammatory corticosteroids also induce vasoconstriction. This can be shown by application of an ethanol solution of the steroid at concentrations of about 1X10 to 1x10" to small 7 x 7 mm. squares of forearm skin for about 20 hrs. and comparison with standard compounds.

The embodiments of the invention in which an exclusive property or privilege is claimed are defined as follows: I

1. A process for the preparation of a steroid compound having the formula.

in which R is oxygen or two hydrogens, said process comprising the following sequential steps:

(a) contacting a steroid of the formula in which R has the same meaning as above, and R is a C -C alkyl with NOF in an inert solvent at a temperature of about -10 to 100 C., under substantially anhydrous conditions, the amount of nitrosyl fluoride being at least about 2 moles per mole of the starting A -ster0id; thus producing the corresponding 5 a-fluoro-6-nitriminosteroid;

(b) contacting the solution of step (a), above, with a weak base to remove excess reagent and acidic reaction side products, and contacting the solution with neutral alumina containing 5-15 weight percent of water to produce the corresponding 5e-fluoro-6- ketosteroid;

(c) contacting the product of step (b), above, at room temperature with about 48 weight percent aqueous hydrofluoric acid to hydrolyze both the 17a,20; 20, 2l-bismethylenedioxy group and the 3-alkanoyloxy group, then acetylating the 3- and 2l-hydroxyls by treating the steroid with acetyl chloride in pyridine solution at or below room temperature;

(d) acetylating the 17-hydroxyl by contacting the product of stepj(c) with acetic anhydride in the presence of p-toluenesulfonic acid at about room temperature;

(e) contacting the product of step ((1), above, with a fiuorinatirig agent selected from sulfur tetrafl'uoride, selenium tetrafiuoride, and phenylsulfur trifluoride, and phenyl'sulfur trifluoride in the presence of a Lewis acid selected from HP, BF and SbF at a temperature of -10 to 100 C. in an inert solvent, and under substantially anhydrous conditions;

with the "proviso that when sulfur tetrafluoride and HF are used, the molar proportion of HF in the mixture does not exceed about thus producing the corresponding 5a,6,6-trifluorosteroid;

(f) contacting the product of step (e), above, dissolved in a water-miscible solvent with aqueous alkali at about --10 to 35 C. to remove the 3-, 17-, and 21- acetylgroups;

(g) reforming the l7a,20; 20, 2l-bisrnethylenedioxy group by contacting the product of step (f), above, in chloroform solution, with aqueous formaldehyde in presence of hydrochloric acid at room temperature, while well agitating the heterogeneous mixture;

(h) oxidizing the 3-hydroxyl to the 3-ketone by contacting the product of step (g), above, in a watermiscible solvent solution with aqueous chromic acid at a temperature not exceeding about 35 C.; and

(i) dehydrofiuorinating the product of step (h), above, in C-4C-5 positions by contacting a solution of said product in hexane with anhydrous, neutral alumina.

2. The process of claim 1 in which the maximum temperature in step (a) is about 30 C.; and the maximum temperature in step (e) is about 30 C., and a mixture of SP with HF is used.

3. A process for the preparation of the steroid compound of claim 1 having the formula from the compound having the formula Q CH 2 CH C O\ O 2 x II in which Z is oxygen, one a-hydrogen and one B-hydroxyl or one a-hydrogen and one group, in which R is a C C alkyl; Y is the nitrimino' group, oxygen or two fluorine atoms; X is the bismethylenedioxy group or the group, in which each of R and R is individually hydrogen or the acetyl group;

and

R is oxygen, two hydrogens, or one rat-hydrogen and one fi-hydroxyl.

5. A steroid compound of claim 4 in which X is the bismethylenedioxy group.

6. A steroid compound of claim 5 in which Y is oxygen; Z is one hydrogen and one hydroxyl; and R is oxygen or two hydrogens.

7. A steroid compound of claim 5 in which Y is two fluorine atoms; Z is' one hydrogen and one acetoxyl; and R is oxygen or two hydrogens. v

8. A steroid compound of claim 5 in which Y is two fluorine atoms; Z is oxygen; and R is oxygen or two hydrogens.

9. A steroid compound of claim 4 in which X is the JHz0R 0:0

group,

R being alkyl, and R being hydrogen.

10. A steroid compound of claim 9 in which Y is oxygen; Z is one hydrogen and one acetoxyl; and R is oxygen or two hydrogens.

11. A steroid compound of claim 9 in which each of R and R is hydrogen; Y is two fluorine atoms; Z is one hydrogen and one hydroxyl; and R is oxygen or two hydrogens.

References Cited UNITED STATES PATENTS 3,546,215 12/1970 Fried 260239.55

ELBERT L. ROBERTS, Primary Examiner US. Cl. X.R. 260397..45; 397.47

P0405) UNITED STATES PATENT OFF'KCE CERTIFICATE OF CURRECTIQN Patent No. 3, 6'41, 005 Dated February 8 1972 Inventor) George .A. Boswell, Jr. and William C. Ripka It is certified that error appears in the above-identified patent and that said Letters Patent are hereby corrected as shown below:

[- Col. 10, line 12, "two-0-CH-O" should be 0 two-0-CH -0 Col. 12, line 52, "percent" should be deleted in both occurrences;

Col. 1 line 58, "and phenylsuliur trifluoride" should be deleted;

Signed and sealed this 26th day of September 1972.

(SEAL) Attest:

EDWARD MeFLETCHER,JILa ROBERT GOTTSCHALK Attesting Officer Commissioner of Patents 

